JULIE KANTER WASHKO: Open Payments
NPI 1902071368 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,576 in 35 payments from 12 companies in 2025. Trend: 2023 $39,979 · 2024 $18,448 · 2025 $51,576
Consulting: $25,156Travel & lodging: $12,567Speaker / faculty: $8,300Honoraria: $4,300Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 5 | $15,306 |
| Terumo BCT, Inc. | 5 | $8,505 |
| PFIZER INC. | 3 | $5,828 |
| Gamida Cell Inc. | 3 | $5,625 |
| Chiesi USA, Inc. | 2 | $5,520 |
| E.R. Squibb & Sons, L.L.C. | 6 | $3,815 |
| Novo Nordisk Health Care AG | 3 | $2,620 |
| F. Hoffmann-La Roche AG | 1 | $1,640 |
| Agios Pharmaceuticals, Inc. | 4 | $1,576 |
| BIOCODEX, INC. | 1 | $1,000 |
Products named: SPECTRA OPTIA, APHEXDA, PYRUKYND, FERRIPROX, Siklos.
Industry payments across AL — which companies pay providers there.
